Search by Drug Name or NDC

    NDC 55150-0329-01 MEDROXYPROGESTERONE ACETATE 150 mg/mL Details

    MEDROXYPROGESTERONE ACETATE 150 mg/mL

    MEDROXYPROGESTERONE ACETATE is a INTRAMUSCULAR INJECTION, SUSPENSION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Eugia US LLC. The primary component is MEDROXYPROGESTERONE ACETATE.

    Product Information

    NDC 55150-0329
    Product ID 55150-329_c9f7d676-5c95-4cc3-b5fb-bc3e8d545847
    Associated GPIs
    GCN Sequence Number 017584
    GCN Sequence Number Description medroxyprogesterone acetate VIAL 150 MG/ML INTRAMUSC
    HIC3 G8C
    HIC3 Description CONTRACEPTIVES,INJECTABLE
    GCN 11251
    HICL Sequence Number 001442
    HICL Sequence Number Description MEDROXYPROGESTERONE ACETATE
    Brand/Generic Generic
    Proprietary Name MEDROXYPROGESTERONE ACETATE
    Proprietary Name Suffix n/a
    Non-Proprietary Name MEDROXYPROGESTERONE ACETATE
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, SUSPENSION
    Route INTRAMUSCULAR
    Active Ingredient Strength 150
    Active Ingredient Units mg/mL
    Substance Name MEDROXYPROGESTERONE ACETATE
    Labeler Name Eugia US LLC
    Pharmaceutical Class Progesterone Congeners [CS], Progestin [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA212824
    Listing Certified Through 2024-12-31

    Package

    NDC 55150-0329-01 (55150032901)

    NDC Package Code 55150-329-01
    Billing NDC 55150032901
    Package 1 VIAL, SINGLE-DOSE in 1 CARTON (55150-329-01) / 1 mL in 1 VIAL, SINGLE-DOSE
    Marketing Start Date 2022-08-22
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 26.2151
    Pricing Unit ML
    Effective Date 2024-02-21
    NDC Description MEDROXYPROGESTERONE 150 MG/ML
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 1, 5
    Classification for Rate Setting G
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis